Production of a streptomycin-Park nucleotide complex by Streptomyces griseus

Antimicrob Agents Chemother. 1989 Jan;33(1):58-62. doi: 10.1128/AAC.33.1.58.

Abstract

A compound (compound X) with antibacterial activity was isolated from early-exponential-phase cultures of the streptomycin producer Streptomyces griseus and from protoplast cultures of the same strain. The protoplast cultures produced a larger amount of compound X than did the young hyphae. Both the mycelia and the protoplasts incorporated 14C-labeled myo-inositol, a precursor of streptomycin, into compound X, which has an amino acid content related to that of the cell wall peptidoglycan of the producer strain. Compound X may contain a streptomycin molecule covalently bound to a cell wall precursor unit, i.e., to a Park nucleotide (J. T. Park, J. Biol. Chem. 194:897-904, 1952), through the glutamic acid of the pentapeptide component.

MeSH terms

  • Anti-Bacterial Agents / analysis
  • Anti-Bacterial Agents / biosynthesis*
  • Cell Wall / analysis
  • Isotope Labeling
  • Molecular Structure
  • Nucleotides / analysis
  • Nucleotides / biosynthesis*
  • Protoplasts / metabolism
  • Streptomyces griseus / metabolism*
  • Streptomycin / biosynthesis*
  • Uridine Diphosphate N-Acetylmuramic Acid / analogs & derivatives
  • Uridine Diphosphate N-Acetylmuramic Acid / isolation & purification*
  • Uridine Diphosphate Sugars / isolation & purification*

Substances

  • Anti-Bacterial Agents
  • Nucleotides
  • Uridine Diphosphate N-Acetylmuramic Acid
  • Uridine Diphosphate Sugars
  • UDP-N-acetylmuramic acid pentapeptide
  • Streptomycin